Found: 32
Select item for more details and to access through your institution.
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 424, doi. 10.1164/rccm.202403-0636OC
- By:
- Publication type:
- Article
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fbrosis.
- Published in:
- BMC Pulmonary Medicine, 2024, p. 1, doi. 10.1186/s12890-024-02957-3
- By:
- Publication type:
- Article
Klimawandel für Lungenfachärzte: ein fokussierter Überblick.
- Published in:
- Kompass Pneumologie, 2024, v. 12, n. 1, p. 4, doi. 10.1159/000535884
- By:
- Publication type:
- Article
Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations: An Official American Thoracic Society Clinical Practice Guideline.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 2, p. 137, doi. 10.1164/rccm.202306-1113ST
- By:
- Publication type:
- Article
Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry.
- Published in:
- Pulmonary Circulation, 2023, v. 13, n. 4, p. 1, doi. 10.1002/pul2.12297
- By:
- Publication type:
- Article
Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults.
- Published in:
- 2022
- By:
- Publication type:
- letter
The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic.
- Published in:
- Journal of Patient Experience, 2022, v. 9, p. 1, doi. 10.1177/23743735221075556
- By:
- Publication type:
- Article
Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic.
- Published in:
- Journal of Patient Experience, 2022, v. 9, p. 1, doi. 10.1177/23743735221075556
- By:
- Publication type:
- Article
Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic.
- Published in:
- Journal of Patient Experience, 2022, v. 9, p. 1, doi. 10.1177/23743735221075556
- By:
- Publication type:
- Article
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 2, p. 471, doi. 10.1007/s41030-021-00162-9
- By:
- Publication type:
- Article
Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 6, p. 1089, doi. 10.3390/diagnostics11061089
- By:
- Publication type:
- Article
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical phenotyping: role in treatment decisions in sarcoidosis.
- Published in:
- European Respiratory Review, 2020, p. 1, doi. 10.1183/16000617.0145-2019
- By:
- Publication type:
- Article
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study.
- Published in:
- European Respiratory Review, 2020, p. 1, doi. 10.1183/16000617.0147-2019
- By:
- Publication type:
- Article
Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.
- Published in:
- Journal of Molecular Medicine, 2018, v. 96, n. 12, p. 1375, doi. 10.1007/s00109-018-1708-8
- By:
- Publication type:
- Article
Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis.
- Published in:
- International Journal of Environmental Research & Public Health, 2018, v. 15, n. 6, p. 1077, doi. 10.3390/ijerph15061077
- By:
- Publication type:
- Article
A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 16077, doi. 10.1038/ncomms16077
- By:
- Publication type:
- Article
Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Naturally Occurring Ozone Air Pollution Episodes on Pulmonary Oxidative Stress and Inflammation.
- Published in:
- International Journal of Environmental Research & Public Health, 2015, v. 12, n. 5, p. 5061, doi. 10.3390/ijerph120505061
- By:
- Publication type:
- Article
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-9
- By:
- Publication type:
- Article
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Smoking, COPD, and 3-Nitrotyrosine Levels of Plasma Proteins.
- Published in:
- Environmental Health Perspectives, 2011, v. 119, n. 9, p. 1314, doi. 10.1289/ehp.1103745
- By:
- Publication type:
- Article
Low-Dose Naltrexone for Pruritus in Systemic Sclerosis.
- Published in:
- International Journal of Rheumatology, 2011, v. 2011, p. 1, doi. 10.1155/2011/804296
- By:
- Publication type:
- Article
Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 26, p. 1, doi. 10.1126/scitranslmed.3000251
- By:
- Publication type:
- Article
The Vascular Micro environment and Systemic Sclerosis.
- Published in:
- International Journal of Rheumatology, 2010, v. 2010, p. 1, doi. 10.1155/2010/362868
- By:
- Publication type:
- Article
A Candidate Gene Approach Identifies the CHRNA5-A3-B4 Region as a Risk Factor for Age-Dependent Nicotine Addiction.
- Published in:
- PLoS Genetics, 2008, v. 4, n. 7, p. 1, doi. 10.1371/journal.pgen.1000125
- By:
- Publication type:
- Article
Transbronchial Biopsy Interpretation in the Patient With Diffuse Parenchymal Lung Disease.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2007, v. 131, n. 3, p. 407
- By:
- Publication type:
- Article
Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking.
- Published in:
- Nicotine & Tobacco Research, 2005, v. 7, n. 6, p. 853, doi. 10.1080/14622200500330209
- By:
- Publication type:
- Article